In this April 2025 issue of Annals of Thoracic Surgery (JCR Q1, IF: 3.6), a retrospective study, led by Professors Jianxing He and Shuben Li from the ...

Sleeve lobectomy is used in a small proportion of nonsmall-cell lung cancer (NSCLC) patients, but a new study suggests that it might have a bigger role to play.

A recent study suggests that sleeve lobectomy is safe to perform in patients with non–small cell lung cancer who received neoadjuvant therapy. In patients with non­–small-cell lung cancer ...

"Initially, the sleeve lobectomy was introduced for patients with lung cancer who were unable to tolerate a full pneumonectomy," stated the study's lead investigator, Yong Soo Choi, MD.

Sleeve resection: Remove a lobe of the lung and a part of the airway. Lobectomy: Cut out an entire lobe of the lung. (The right lung is divided into three lobes; the left lung has two lobes.) ...

One study found that those treated with sleeve lobectomy had a 62.7% 5-year survival rate compared to 43.1% for those treated with pneumonectomy.

On the basis of the results of the landmark study by Ginsberg et al 3 in the 1980s, lobectomy has been considered the optimal mode of pulmonary resection for lung cancer when combined with clearance ...

Non-small-cell lung cancer develops when normal cells mutate and begin to divide and grow rapidly in lung tissue. Once diagnosed, your doctor will see how far it has spread to determine the amount ...

Patients were split between the 823,746 who received surgery prior to the COVID-19 pandemic (January 2016 through December 2019) and the 164,690 patients who had surgery during the pandemic ...

Compared with gross total resection, lobectomy as a surgical intervention for individuals with glioblastoma had a more positive impact on progression-free and overall survival outcomes, according ...